LGALS3 and metabolic dysfunction-associated steatohepatitis: In a swine model of NASH, the expression of the LGALS3 gene is upregulated during the transition from steatosis to steatohepatitis, and increased expression of LGALS3 may be used in the evaluation of disease progression [137].